一个脂肪栓塞综合征病例用甲基普雷尼索隆治疗
Daisuke Baba1, Yugo Yamashita1, Yuki Fukuda1
1Department of Cardiovascular Medicine, Kyoto University Hospital, Japan.
Internal medicine (Tokyo, Japan)
|December 25, 2024
概括
高剂量的甲基普雷迪尼索隆可以改善脂肪栓塞综合征 (FES) 患者的血液动力状况. 这项案例研究表明,当标准治疗在这种罕见但严重的术后并发症中失败时,其潜在的疗效.
科学领域:
- 医学案例研究 医学案例研究
- 关键护理医学 关键护理医学
- 整形外科手术并发症 整形外科手术并发症
背景情况:
- 脂肪栓塞综合征 (FES) 是骨科手术后的一种罕见但可能危及生命的并发症.
- 突然呼吸不全和右心室扩张可以模仿肺栓塞,使诊断复杂化.
- 在严重的FES病例中,标准的血液动力学支持可能不足.
研究的目的:
- 在骨科手术后报告FES病例.
- 调查高剂量甲基普雷迪尼索隆在FES中治疗耐火性血液动力学不稳定性的有效性.
- 突出FES管理的潜在治疗选择.
主要方法:
- 一名74岁的女性患者在骨科手术后突然出现呼吸障碍.
- 心声学表明急性肺栓塞,但CT排除了血栓栓塞,导致FES的怀疑.
- 在初始的血管压缩剂和无otropic 支持未能改善血液动力学后,高剂量的甲基prednisolone 被管理.
主要成果:
- 患者经历了迅速的血液动力学改善,并在高剂量甲基普雷迪尼索隆给药后达到血压正常.
- 对比计算机断层扫描证实没有肺血栓栓塞,支持FES的诊断.
- 最初用诺拉上腺素和多布他胺治疗是无效的.
结论:
- 高剂量的甲基prednisolone可能是一个可行的治疗选择,以改善脂肪栓塞综合征的血液动力状况.
- 这一案例强调了在术后患有无法解释的血液动力学损害的患者中考虑FES的重要性.
- 需要进一步的研究来确定皮质类固醇在FES管理中的作用.
更多相关视频
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
2.0K
07:10Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
Published on: May 20, 2019
13.4K
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
934
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
934
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
84
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
84
01:29Chronic Pancreatitis II: Collaborative Care
46
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
46